Abstract
AbstractThe ligand‐based virtual screening of an original chemical library, using atypical antipsychotics as query compounds led to the identification of a novel scaffold with inhibitory activity at the 5‐HT2A serotonin receptor. The hit compounds were confirmed by pharmacological evaluation at the 5‐HT2A receptor and complemented by the selection of other representatives of the same chemical family within our chemical library. A promising scaffold of 6‐(pyperazin‐1‐yl) purine was identified, and the binding mode is illustrated with an automated docking exploration on a homology built model of the 5‐HT2A receptor. The present results constitute an excellent starting point for the discovery of new chemical entities with antipsychotic activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
